GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (NYSE:A) » Definitions » Scaled Net Operating Assets

A (Agilent Technologies) Scaled Net Operating Assets : 0.72 (As of Oct. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Agilent Technologies Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Agilent Technologies's operating assets for the quarter that ended in Oct. 2024 was $10,517 Mil. Agilent Technologies's operating liabilities for the quarter that ended in Oct. 2024 was $2,558 Mil. Agilent Technologies's Total Assets for the quarter that ended in Jul. 2024 was $10,996 Mil. Therefore, Agilent Technologies's scaled net operating assets (SNOA) for the quarter that ended in Oct. 2024 was 0.72.


Agilent Technologies Scaled Net Operating Assets Historical Data

The historical data trend for Agilent Technologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Scaled Net Operating Assets Chart

Agilent Technologies Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.68 0.66 0.66 0.74

Agilent Technologies Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.65 0.65 0.65 0.72

Competitive Comparison of Agilent Technologies's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Agilent Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilent Technologies's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's Scaled Net Operating Assets falls into.



Agilent Technologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Agilent Technologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Oct. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Oct. 2024 )
=(Operating Assets (A: Oct. 2024 )-Operating Liabilities (A: Oct. 2024 ))/Total Assets (A: Oct. 2023 )
=(10517-2558)/10763
=0.74

where

Operating Assets(A: Oct. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=11846 - 1329
=10517

Operating Liabilities(A: Oct. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=5948 - 3345 - 45
=2558

Agilent Technologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Oct. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Oct. 2024 )
=(Operating Assets (Q: Oct. 2024 )-Operating Liabilities (Q: Oct. 2024 ))/Total Assets (Q: Jul. 2024 )
=(10517-2558)/10996
=0.72

where

Operating Assets(Q: Oct. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=11846 - 1329
=10517

Operating Liabilities(Q: Oct. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=5948 - 3345 - 45
=2558

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Agilent Technologies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilent Technologies Business Description

Address
5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Executives
Padraig Mcdonnell officer: Senior Vice President 5301 STEVENS CREEK BLVD, SANTA CLARA CA 95051
Dominique Grau officer: Senior Vice President 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Philip Binns officer: Senior Vice President 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Michael R. Mcmullen officer: CEO and President 5301 STEVENS CREEK BLVD., MS 1A-LC, SANTA CLARA CA 95051
Rodney Gonsalves officer: V.P., Corporate Controller 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Heidi Fields director 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Henrik Ancher-jensen officer: Sr. Vice President 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
George A Scangos director C/O EXELIXIS INC, 170 HARBOR WAY, SAN FRANCISCO CA 94083
Otis W Brawley director 5203 BRISTOL INDUSTRIAL WAY, BUFORD GA 30518
Mikael Dolsten director 5 GIRALDA FARMS, MADISON NJ 07940
Mala Anand director C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Sue H. Rataj director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Dow R Wilson director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Boon Hwee Koh director C/O AGILENT TECHNOLOGIES, 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051
Hans Edgar Bishop director 60 WEST 66TH STREET, 26A, NEW YORK NY 10023